Year-over-year, this metric declined by 91.2%, from $61.70M to $5.40M. Over 3 years (FY 2021 to FY 2025), Other Income (Expense) shows an upward trend with a 245.8% CAGR.
An increase suggests higher non-operating gains or lower non-operating costs, while a decrease indicates higher non-operating expenses or lower non-operating income.
Represents the net total of non-operating financial activities, including interest income, interest expense, foreign cur...
Standard across all public companies; peers in the medical device sector often show similar volatility due to currency fluctuations.
other_income_expense_net| Q1 '21 | Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$1.20M | $0.00 | -$200.00K | -$100.00K | $0.00 | -$100.00K | -$200.00K | -$100.00K | -$100.00K | $100.00K | -$200.00K | -$100.00K | $0.00 | -$100.00K | $29.30M | $61.70M | $400.00K | -$100.00K | $0.00 | $5.40M |
| QoQ Change | — | +100.0% | — | +50.0% | +100.0% | — | -100.0% | +50.0% | +0.0% | +200.0% | -300.0% | +50.0% | +100.0% | — | >999% | +110.6% | -99.4% | -125.0% | +100.0% | — |
| YoY Change | — | — | — | — | +100.0% | — | +0.0% | +0.0% | — | +200.0% | +0.0% | +0.0% | -100.0% | +50.0% | — | >999% | — | +0.0% | -100.0% | -91.2% |
| Segment | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 |
|---|---|---|---|---|
| Cost of sales | $0.00 | $0.00 | $0.00 | $0.00 |
| Total | $61.70M | $400.00K | -$100.00K | $0.00 |
Cost of sales was previously reported and has since been discontinued or reclassified. Only currently active segments are shown in the chart.